Rigo V - Search Results

1

New immunotherapeutic strategies for the treatment of neuroblastoma.

Croce M, Corrias MV, Rigo V, Ferrini S. Croce M, et al. Among authors: rigo v. Immunotherapy. 2015;7(3):285-300. doi: 10.2217/imt.14.117. Immunotherapy. 2015. PMID: 25804480 Review.

2

Transient depletion of CD4(+) T cells augments IL-21-based immunotherapy of disseminated neuroblastoma in syngeneic mice.

Croce M, Corrias MV, Orengo AM, Brizzolara A, Carlini B, Borghi M, Rigo V, Pistoia V, Ferrini S. Croce M, et al. Among authors: rigo v. Int J Cancer. 2010 Sep 1;127(5):1141-50. doi: 10.1002/ijc.25140. Int J Cancer. 2010. PMID: 20039320 Free article.

3

Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity.

Rigo V, Corrias MV, Orengo AM, Brizzolara A, Emionite L, Fenoglio D, Filaci G, Croce M, Ferrini S. Rigo V, et al. Cancer Immunol Immunother. 2014 May;63(5):501-11. doi: 10.1007/s00262-014-1536-9. Epub 2014 Mar 20. Cancer Immunol Immunother. 2014. PMID: 24647609 Free PMC article.

4

IL-21: a pleiotropic cytokine with potential applications in oncology.

Croce M, Rigo V, Ferrini S. Croce M, et al. Among authors: rigo v. J Immunol Res. 2015;2015:696578. doi: 10.1155/2015/696578. Epub 2015 Apr 15. J Immunol Res. 2015. PMID: 25961061 Free PMC article. Review.

5

IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome.

Morandi F, Croce M, Cangemi G, Barco S, Rigo V, Carlini B, Amoroso L, Pistoia V, Ferrini S, Corrias MV. Morandi F, et al. Among authors: rigo v. J Immunol Res. 2015;2015:718975. doi: 10.1155/2015/718975. Epub 2015 Apr 19. J Immunol Res. 2015. PMID: 25961062 Free PMC article.

6

Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival.

Stigliani S, Croce M, Morandi F, Scaruffi P, Rigo V, Carlini B, Manzitti C, Gigliotti AR, Tonini GP, Pistoia V, Ferrini S, Corrias MV. Stigliani S, et al. Among authors: rigo v. Biomed Res Int. 2015;2015:347867. doi: 10.1155/2015/347867. Epub 2015 Jun 16. Biomed Res Int. 2015. PMID: 26161395 Free PMC article.

7

Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.

Petretto A, Carbotti G, Inglese E, Lavarello C, Pistillo MP, Rigo V, Croce M, Longo L, Martini S, Vacca P, Ferrini S, Fabbi M. Petretto A, et al. Among authors: rigo v. Oncotarget. 2016 Nov 8;7(45):72518-72536. doi: 10.18632/oncotarget.12235. Oncotarget. 2016. PMID: 27683036 Free PMC article.

8

Altered erythropoiesis and decreased number of erythrocytes in children with neuroblastoma.

Morandi F, Barco S, Stigliani S, Croce M, Persico L, Lagazio C, Scuderi F, Belli ML, Montera M, Cangemi G, Pozzi S, Rigo V, Scaruffi P, Amoroso L, Erminio G, Pistoia V, Ferrini S, Corrias MV. Morandi F, et al. Among authors: rigo v. Oncotarget. 2017 May 30;8(32):53194-53209. doi: 10.18632/oncotarget.18285. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881804 Free PMC article.

9

Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma.

Rigo V, Emionite L, Daga A, Astigiano S, Corrias MV, Quintarelli C, Locatelli F, Ferrini S, Croce M. Rigo V, et al. Sci Rep. 2017 Oct 25;7(1):14049. doi: 10.1038/s41598-017-14417-6. Sci Rep. 2017. PMID: 29070883 Free PMC article.

10

Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.

Amaro A, Reggiani F, Fenoglio D, Gangemi R, Tosi A, Parodi A, Banelli B, Rigo V, Mastracci L, Grillo F, Cereghetti A, Tastanova A, Ghosh A, Sallustio F, Emionite L, Daga A, Altosole T, Filaci G, Rosato A, Levesque M, Maio M, Pfeffer U, Croce M; EPigenetic Immune-oncology Consortium Airc (EPICA) consortium. Amaro A, et al. Among authors: rigo v. J Exp Clin Cancer Res. 2023 Mar 18;42(1):67. doi: 10.1186/s13046-023-02628-x. J Exp Clin Cancer Res. 2023. PMID: 36934257 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page